The present invention provides an N1-cyclic amine-N5-substituted biguanide derivative compound represented by Formula 1, a method of preparing the same and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an actice ingredient. The biguanide derivatives have an effect of inhibiting cancer cell proliferation, cancer metastasis and cancer recurrence by activation of AMPK, even when administered in a small dose compared with conventional drugs.
本发明提供了一种由式1表示的N1-环
氨基-N5-取代双胍衍
生物化合物,以及制备该化合物的方法和包括双胍衍
生物或其药学上可接受的盐作为活性成分的药物组合物。与传统药物相比,即使以小剂量给药,双胍衍
生物通过激活
AMPK具有抑制癌细胞增殖、癌转移和癌复发的作用。